ZHUHAI YUFAN BIOTECHNOLOGIES CO LTD has a total of 13 patent applications. Its first patent ever was published in 2018. It filed its patents most often in WIPO (World Intellectual Property Organization), China and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are AXXIMA PHARMACEUTICALS AG, BANTAM PHARMACEUTICAL LLC and EPIZYME INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | China | 3 | |
#3 | Australia | 1 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement | |
#4 | Biotechnology | |
#5 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Analysing materials | |
#5 | Peptides | |
#6 | Climate change mitigation in goods production |
# | Name | Total Patents |
---|---|---|
#1 | Liao Xuebin | 8 |
#2 | Lin Xingyu | 4 |
#3 | Xuebin Liao | 2 |
#4 | Lu Tingting | 2 |
#5 | Liu Yahui | 1 |
#6 | Sun Shuhao | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021057872A1 | Protac small molecule compound and application thereof | |
WO2021018012A1 | Irak4 kinase inhibitor and preparation method therefor | |
WO2020207260A1 | Cdk inhibitor and application thereof | |
CN111662295A | IRAK4 kinase inhibitor and preparation method thereof | |
WO2019206049A1 | Hpk1 inhibitors, preparation method and application thereof | |
CN110396088A | HPK1 kinase inhibitor, preparation method and applications |